你希望谁来为你进行非保护左主干经皮冠状动脉介入治疗？ - Suppr

Suppr

超能文献

Who Would You Want to Do Your Unprotected Left Main Percutaneous Coronary Intervention?

作者信息

Saad Marwan, Brilakis Emmanouil S

机构信息

Lifespan Cardiovascular Institute Warren Alpert Medical School of Brown University Providence RI.

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation Abbott Northwestern Hospital Minneapolis MN.

出版信息

J Am Heart Assoc. 2020 May 5;9(9):e016699. doi: 10.1161/JAHA.120.016699. Epub 2020 Apr 29.

DOI:10.1161/JAHA.120.016699

PMID:32347152

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7428559/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e49/7428559/7983bba87c4b/JAH3-9-e016699-g001.jpg

相似文献

Who Would You Want to Do Your Unprotected Left Main Percutaneous Coronary Intervention?你希望谁来为你进行非保护左主干经皮冠状动脉介入治疗？

J Am Heart Assoc. 2020 May 5;9(9):e016699. doi: 10.1161/JAHA.120.016699. Epub 2020 Apr 29.

Characteristics and outcomes of patients with percutaneous coronary intervention for unprotected left main coronary artery disease: a Hong Kong experience.非保护左主干冠状动脉疾病患者经皮冠状动脉介入治疗的特征与结果：香港经验

Hong Kong Med J. 2014 Jun;20(3):187-93. doi: 10.12809/hkmj134069. Epub 2014 May 9.

Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局：DELTA 注册研究（左主干冠状动脉疾病药物洗脱支架）：一项多中心注册研究，评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。

JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.

Left Main Disease: What Is the Correct Approach to Revascularization?左主干病变：血运重建的正确方法是什么？

Cardiol Rev. 2018 Sep/Oct;26(5):219-229. doi: 10.1097/CRD.0000000000000213.

The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.DELTA 2 注册研究：一项多中心注册研究，旨在评估新型药物洗脱支架经皮冠状动脉介入治疗伴左主干病变的患者。

JACC Cardiovasc Interv. 2017 Dec 11;10(23):2401-2410. doi: 10.1016/j.jcin.2017.08.050.

Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.比较单纯血管造影方法与紫杉醇经皮冠状动脉介入治疗和心脏手术评分方法在左主干冠状动脉支架置入中的协同作用：系列 PRECOMBAT（使用依维莫司洗脱支架在左主干冠状动脉疾病患者中进行旁路手术与血管成形术的随机比较的首项研究）的汇总分析。

Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374.

Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。

Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.

Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).比较药物洗脱支架经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干严重狭窄的女性患者（来自女性药物洗脱支架治疗左主干冠状动脉疾病登记研究）。

Am J Cardiol. 2014 Apr 15;113(8):1348-55. doi: 10.1016/j.amjcard.2014.01.409. Epub 2014 Jan 31.

Drug-eluting stents in unprotected left main coronary artery disease.

Expert Rev Cardiovasc Ther. 2014 Nov;12(11):1349-68. doi: 10.1586/14779072.2014.967215.

Current Interventions for the Left Main Bifurcation.左主干分叉病变的现行介入治疗

JACC Cardiovasc Interv. 2017 May 8;10(9):849-865. doi: 10.1016/j.jcin.2017.02.037.

引用本文的文献

Impact of Operator Volumes and Experience on Outcomes After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program.经皮冠状动脉介入治疗后术者手术量和经验对结局的影响：来自退伍军人事务部临床评估、报告和跟踪（CART）计划的见解。

Cardiovasc Revasc Med. 2022 Jul;40:64-68. doi: 10.1016/j.carrev.2021.11.008. Epub 2021 Nov 6.

本文引用的文献

Procedural Volume and Outcomes After Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery DiseaseReport From the National Clinical Data (J-PCI Registry).经皮冠状动脉介入治疗无保护左主干冠状动脉疾病的操作量和结局：来自全国临床数据（J-PCI 注册研究）的报告。

J Am Heart Assoc. 2020 May 5;9(9):e015404. doi: 10.1161/JAHA.119.015404. Epub 2020 Apr 29.

Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database.血管内影像学检查与非保护左主干 PCI 术后 12 个月死亡率：来自英国心血管介入学会数据库的分析。

JACC Cardiovasc Interv. 2020 Feb 10;13(3):346-357. doi: 10.1016/j.jcin.2019.10.007.

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄：NOBLE 随机非劣效性试验的 5 年更新结果。

Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.左主干冠状动脉疾病经皮冠状动脉介入治疗或冠状动脉旁路移植术后 5 年的结果。

N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.

Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures.血管内超声指导下经皮冠状动脉介入治疗对复杂手术患者长期临床结局的影响。

JACC Cardiovasc Interv. 2019 Apr 8;12(7):607-620. doi: 10.1016/j.jcin.2019.01.227. Epub 2019 Mar 13.

Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.术者手术量与经皮冠状动脉介入治疗后长期结局的关系。

Circulation. 2019 Jan 22;139(4):458-472. doi: 10.1161/CIRCULATIONAHA.117.033325.

Operator volume is not associated with mortality following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society registry.术者量与经皮冠状动脉介入治疗后的死亡率无关：来自英国心血管介入学会注册中心的见解。

Eur Heart J. 2018 May 7;39(18):1623-1634. doi: 10.1093/eurheartj/ehy125.

The Volume-Outcome Relationship Revisited: Does It Matter for High-Risk PCI?再探容量-结局关系：这对高风险经皮冠状动脉介入治疗重要吗？

JACC Cardiovasc Interv. 2016 Oct 24;9(20):2094-2096. doi: 10.1016/j.jcin.2016.08.033.

Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention.术者经验和手术量对左主干经皮冠状动脉介入治疗结局的影响。

JACC Cardiovasc Interv. 2016 Oct 24;9(20):2086-2093. doi: 10.1016/j.jcin.2016.08.011.

ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures).ACCF/AHA/SCAI 2013年冠状动脉介入手术临床能力声明更新：美国心脏病学会基金会/美国心脏协会/美国内科医师学会临床能力与培训特别工作组（修订2007年心脏介入手术临床能力声明写作委员会）报告

J Am Coll Cardiol. 2013 Jul 23;62(4):357-96. doi: 10.1016/j.jacc.2013.05.002. Epub 2013 May 8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验